IN BRIEF (Page 14)
China Daily | Updated: 2008-10-16 08:05
New R&D center
Pharmaceutical firm Eli Lilly and Company announced yesterday it has opened an R&D headquarters in China. The Shanghai office will house a scientific management and venture investment team.
"China, with its vast supply of scientific talents, vibrant entrepreneurs and superb infrastructure, will become a fertile ground to define the winning model of future drug R&D," said Robert Armstrong, vice-president of Lilly's global external research and development.
Photo
